BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

Similar documents
Integration with your EllucianSystems

Textbook, MyEconLab, and Differences Between Editions

Massive Haemorrhage J Davies B Ferguson

TAYSIDE GUIDE TO MASSIVE TRANSFUSION/BLOOD LOSS

Western Region If you can read this tghen Alzheimer's is a long, way down the road before it ever gets anywhere near you.

CONTINUATION TRAINING

Blood Product Utilization

Category Storage Shelf Life Additional Criteria

CHANGE IN PLATELET USAGE

Obstetrical (OB) Hemorrhage Guidelines

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Physician Orders - Adult

Massive Transfusion Protocol (MTP)

NHSBT Portfolio of Blood Components and Guidance for their Clinical Use. Summary of Significant Changes. Purpose. Definitions. Applicable Documents

Red Cell Transfusion LESSONS FROM TRAUMA

BASIC GUIDE TO TEG INTERPRETATION

Note: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

BLOOD ADMINISTRATION PROTOCOL

Contents. Blood Products 2. ABO System 3. Rh System 3. Transfusion Risks 5 Equipment Cell Saver 7 Procedures... 7

Coagulation in perspective: Blood management. Objectives

Grading: This project is worth a total of 300 points (Resume 100; Cover Letter 100; Job Application 100).

HEMOCHRON. Whole Blood Coagulation Systems

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

Factor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate

DRUG NAME : Clexane (enoxaparin) Pre-Filled Syringes

Marcia L. Zucker, Ph.D. ZIVD LLC

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

ROTEM Basic Interpretation Guide

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

ROTEM/TEG. Circulation in trauma: From roadside to bedside. A/Prof David Roxby SA Pathology Transfusion Service South Australia

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) CORE SPC FOR HUMAN PLASMA DERIVED AND RECOMBINANT COAGULATION FACTOR IX PRODUCTS

PATHOLOGY HANDBOOK. Revision 3. (Review date November 2020) HAEMATOLOGY and BLOOD TRANSFUSION

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

GUIDELINES for PRETRANSFUSION LABORATORY PRACTICE

On-Site Specialty Analyzer

Special Specimen Collection Procedures for Coagulation Testing

Pre-Analytic Issues in Laboratory Medicine

Component Preparation, Manufacturing and Modifications

TRACEABILITY USER MANUAL

Factors That Promote Increase In POC Testing

Anti- THrombosis with Enoxaparin in intubated Adolescents

Virtual Lectures Planning Committee Disclosure Summary

Paul Ashford Executive Director ICCBBA

ABO Typing Discrepancies

Immunohematology Practicum Objectives - CLS 645

UPDATE ON SPECIFIC ANTIDOTES FOR TARGET-SPECIFIC ORAL ANTICOAGULANTS

SEED Coagulation. Sysmex Educational Enhancement and Development April 2014

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin

Coagulation: The Ins and Outs. Sheila K. Coffman BSMT (ASCP)

Elevated Immunoglobulins and Paraproteins

Marcia L. Zucker, Ph.D. ZIVD LLC

With Stago, discover an outstanding Routine range

Residual Serum Thrombin

Haemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis

POLICY FOR THE PROVISION OF PERIOPERATIVE RED CELL SALVAGE JOINT TRANSFUSION COMMITTEE PATIENT RELATED POLICIES

Laboratory Tests Chronic Renal Deficiency (CRD) Patients (NCD )

Efficacy and tolerability of human fibrinogen concentrate

Macopharma Blood Safety Symposium. THERAFLEX Pathogen Reduction Technologies

GENUS WORLD ANOTHER GOLDEN YEAR FOR GENUS. Winter 2011/12 LEADING THE WORLD IN BOVINE AND PORCINE ANIMAL GENETICS

Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation

Progress Report: T h e Activated Coagulation. T i m e of Whole Blood (ACT)

I-STAT POCT System PRINCIPLE:

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Deep dive into anticoagulant reversal In 20 minutes so we won t dive too deep. Mark Crowther on behalf many Some slides modified from other sources

IG Production and Safety

autolog Autotransfusion System

Apheresis Anticoagulant Removal. Oluwatoyosi Onwuemene, MD MS May 6th, 2017

World Health Organization. Standard-setting Activities Impact on Global Health

PRETRANSFUSION OR COMPATIBILITY TESTING

DISTRIBUTION AND SUPPLY OF PLASMA DERIVED FRACTIONATED BLOOD PRODUCTS AND RECOMBINANT PRODUCTS IN NEW ZEALAND

Journal What will YOU change? Formerly. Issue 27, Winter 2013

R.Li, C.Swaelens, F.Vandermijnsbrugge, B.Cantinieaux BSTH Laboratory of haematology, Porte de Hal,

Comparison of Several Activated Partial Thromboplastin Time Methods

Biotechnology of Human Plasma-Derived Medicines in Scope of Collaboration Perspectives within The Central European Initiative

BIOVIGILANCE IN THE UNITED STATES: Regulatory Perspective

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong

Title: Hemoglobin HemoCue Hb 301 method

Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017

Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for

SAMPLE. Determination of Coagulation Factor Activities Using the One-Stage Clotting Assay

Drugs used in Thromboembolic Disease. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014

Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

The clinical utility of IPF in thrombocytopenia

GUIDE FOR THE ASSESSMENT OF CLOTTING FACTOR CONCENTRATES

Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4

Transcription:

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

What Are The Risks Associated With Blood Transfusion? Infection transmission Hepatitis B Hepatitis C HIV Syphilis vcjd? Transfusion of the wrong blood!!!

Transfusion Case Study Patient dies following transfusion Elderly man with chronic renal failure, anaemia and a history of falls attends A&E Symptomatically anaemic with Hb 6.8 g/dl. Cross matched using a blood sample taken in A&E On ITU after < 100 mlblood had been transfused, developed fever, hypotension, bronchospasmand died a few hours later On investigation: Patient blood was group O RhD negative, he received a unit of A RhD negative blood.

What went wrong? No checking of patient s ID at the bedside, either with the patient or with the wristband. Incorrect patient had been bled in A&E resulting in a wrong blood in a tube incident. The sample was labelled for the intended patient. Why? Transfusion sample protocol not followed. What should have happened? All patients being sampled must be positively identified. Reaction? Acute Haemolytic Transfusion Reaction

Sampling Procedure Step 1: Ask the patient to tell you their: Full name and date of birth Check this information against the patient s ID wristband Get a second independent check when the patient is unconscious / compromised

Sampling Procedure Step 2: Check the patient s ID wristband against documentation e.g. case notes or transfusion request form: First name Surname Date of birth Hospital number

Sampling Procedure Only bleed one patient at a time Do NOT use pre-labelled tubes Hand write the sample tube before leaving the patients side! NB: Do not take samples from a IV drip arm.

Blood Request Card Mandatory Fields Please Note: All patients requiring blood products will require two group and screen samples to be taken at separate times in order to verify the patient s correct blood type. Unless there is an existing historical blood group record when an in date second sample will be required. Certain haematology patients must be treated with Hepatitis E (HEV) negative products Please refer to CORP/PROT/327 or contact blood bank Tel 3746/3747 for advice

Why do mistakes happen? Not following the trust policy Only seeing what you want to see when checking products / patient ID Relying on the other person to carryout the check Labelling blood tubes away from the patient Remotely carrying out the bedside check

Do you always see what your reading? I cdnuolt blveiee taht I cluod aulaclty uesdnatnrd waht I was rdgnieg. The phaonmneal pweor of the hmuan mnid Aoccdrnig to a rscheearch at Cmabrigde Uinervtisy, it deosn't mttaer inwaht oredr the ltteers in a wrod are, the olny iprmoatnt tihng is taht the frist and lsat ltteer be in the rghit pclae. The rset can be a taotl mses and you can sitll raed it wouthit a porbelm. Tihs is bcuseae the huamn mnid deos not raed ervey lteter by istlef, but the wrod as a wlohe. Amzanig huh? yaeh and I awlyas thought slpeling was ipmorantt!

What do you see? PARIS IN THE THE SPRING

WHAT DO YOU KNOW ABOUT BLOOD TRANSFUSION? WHAT IS THE AVERAGE VOLUME OF A BAG OF PACKED RED CELLS 280 MLS 350 MLS 450 MLS

AVERAGE VOLUME IS 280Mls Approx 450mls is collected from donors Blood is then fractionated into plasma For FFP/cryoprecipitate, platelets and RBCs RBCs are re-suspended in nutrient medium and issued

HOW MUCH DO YOU KNOW ABOUT BLOOD TRANSFUSION? A patient's platelet count is 20 x 10 9 /l; one bag of platelets will raise it to A. 70 B. 100 C. 30

PLATELET COUNT WILL RISE TO APPROX. 70 x10 9 /l One adult dose of platelets is derived from 4 pooled donations and combined in one bag Platelet count will rise by approx 50 after one adult dose

HOW MUCH DO YOU KNOW ABOUT BLOOD TRANSFUSION? A patient weighs 70kg and requires FFP the correct dose is; A. 20-30ml/kg B. 12-15ml/kg C. 5-10ml/kg

THE CORRECT DOSE OF FFP IS 12-15 ml/kg A 70kg patient would need 3/4 bags. No viral inactivation steps taken Contains all clotting factors Should not be used as a volume expander

Warfarin Reversal Before An Urgent Or Emergency Operation There is no role at BVH for the use of fresh frozen plasma (FFP) in the reversal of anticoagulation. The preferred agent is prothrombin complex concentrate (PCC). (Octoplex) PCC has the following advantages over FFP: No need for a blood group No need to thaw Small volume to give to patients (approximately 20mls compared to about 1 litre of FFP), which will be beneficial in elderly patients No risk of FFP-associated side-effects such as anaphylaxis or transfusion-related acute lung injury (TRALI)

FACTS ABOUT TRANSFUION! There are NO clotting factors in red cells There are no active platelets in red cells Blood transfusion must be completed within 4 hours of removal from fridge BUT 280mls can be safely transfused into most patients over 2 to 3 hours

THE GREATEST RISK TO A PATIENT HAVING A BLOOD TRANSFUION IS? A. Getting post transfusion hepatitis B. Getting HIV C. You

Insert local arrangements: Activation Tel Number(s) Switchboard 2222 Emergency O red cells -laboratory issue room * Time to receive at this clinical area: Group specific red cells 20 minutes XM red cells 45 minutes STOP THE BLEEDING Haemorrhage Control Direct pressure / tourniquet if appropriate Stabilise fractures Surgical intervention Interventional radiology Endoscopic techniques Obstetric techniques Haemostatic Drugs Tranexamic acid 1g bolus followed by 1g over 8 hrs Vit K and Prothrombin complex concentrate for warfarinised patients and Other haemostatic agents: discuss with Consultant Haematologist Cell salvage if available and appropriate Consider ratios of other components: 1 unit of red cells = c.250 mls salvaged blood Transfusion lab 3746 /3747 Consultant Haematologist Via switchboard Transfusion Management of Massive Haemorrhage Patient bleeding / collapses Ongoing severe bleeding eg:150 mls/min Clinical shock Activate Massive Haemorrhage Pathway Call for help Massive Haemorrhage, Location, Specialty Alert emergency response team (including blood transfusion laboratory, portering/ transport staff) Consultant involvement essential Take bloods and send to lab: XM, FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available and Order MHP 1 Red cells* 4 units (*Emergency O blood, group specific blood, XM blood depending on availability) FFP 4 units Give MHP 1 Reassess Suspected continuing haemorrhage requiring further transfusion Take bloods and send to lab: FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available Order MHP 2 Red cells 4 units FFP 4 units Platelets 1 dose (ATD) and subsequently request Cryoprecipitate 2 packs if fibrinogen <1g/l (or < 2g/l in obstetric haemorrhage) or according to TEG / ROTEM Give MHP 2 Once MHP 2 administered, repeat bloods: FBC, PT, APTT, fibrinogen, U+E, NPT: ABG, TEG / ROTEM if available To inform further blood component requesting Thromboprophylaxis should be considered when patient stable RESUSCITATE Airway Breathing Circulation Prevent Hypothermia Use fluid warming device Used forced air warming blanket Consider 10 mls Calcium chloride 10% over 10 mins 2 packs cryoprecipitate if fibrinogen < 1g/l (<2g/l in obstetric haemorrhage) or as guided by TEG / ROTEM Aims for therapy Aim for: Hb 8-10g/dl Platelets >75 x 10 9 /l PT ratio < 1.5 APTT ratio <1.5 Fibrinogen >1g/l Ca 2+ >1 mmol/l Temp > 36 o C ph > 7.35 (on ABG) Monitor for hyperkalaemia ABG Arterial Blood Gas APTT Activated partial thromboplastin time ATD- Adult Therapeutic Dose FFP- Fresh Frozen plasma MHP Massive Haemorrhage Pack NPT Near Patient Testing STAND DOWN Inform lab Return unused components Complete documentation Including audit proforma

THE ONLY SAFE TRANSFUSION IS? THE ONE YOU DON T GET!